Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. by 諛뺤듅�슦
Oncogenic KRAS induces progenitor cell expansion and
malignant transformation in zebrafish exocrine pancreas
Seung Woo Park1, Jon M Davison2, Jerry Rhee1, Ralph H. Hruban2,3, Anirban Maitra2,3, and
Steven D Leach1,3,4
1Department of Surgery, The Sol Goldman Center for Pancreatic Cancer Research, Johns Hopkins University
School of Medicine, Baltimore, MD 21205
2Department of Pathology, The Sol Goldman Center for Pancreatic Cancer Research, Johns Hopkins
University School of Medicine, Baltimore, MD 21205
3Department of Oncology, The Sol Goldman Center for Pancreatic Cancer Research, Johns Hopkins
University School of Medicine, Baltimore, MD 21205
4Department of Cell Biology, The Sol Goldman Center for Pancreatic Cancer Research, Johns Hopkins
University School of Medicine, Baltimore, MD 21205
Abstract
Background and Aims—Although the cell of origin for pancreatic cancer remains unknown,
prior studies have suggested that pancreatic neoplasia may be initiated in progenitor-like cells. In
order to examine the effects of oncogene activation within the pancreatic progenitor pool, we devised
a system for real-time visualization of both normal and oncogenic KRAS-expressing pancreatic
progenitor cells in living zebrafish embryos.
Methods—Using BAC transgenes under the regulation of ptf1a regulatory elements, we expressed
either GFP alone or GFP fused to oncogenic KRAS in developing zebrafish pancreas.
Results—Following their initial specification, normal GFP-labeled pancreatic progenitor cells were
observed to actively migrate away from the forming endodermal gut tube, and subsequently
underwent characteristic exocrine differentiation. In contrast, pancreatic progenitor cells expressing
oncogenic KRAS underwent normal specification and migration, but failed to differentiate. This
block in differentiation resulted in the abnormal persistence of an undifferentiated progenitor pool,
and was associated with the subsequent formation of invasive pancreatic cancer. These tumors
exhibited several features in common with the human disease, including evidence of abnormal
Hedgehog pathway activation.
Conclusions—These results provide a unique view of the tumor-initiating effects of oncogenic
KRAS in a living vertebrate organism, and suggest that zebrafish models of pancreatic cancer may
prove useful in advancing our understanding of the human disease.
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Introduction
In both mouse and human, exocrine pancreatic cancer appears to be initiated by oncogenic
KRAS. In humans, over 90% of all pancreatic ductal adenocarcinomas show evidence of
oncogenic KRAS mutations, and evaluation of pancreatic cancer precursor lesions suggests
that these mutations represent an early event in pancreatic tumorigenesis 1, 2. In mice,
expression of oncogenic KRAS is sufficient to induce pancreatic intraepithelial neoplasia
(PanIN), a known precursor for invasive pancreatic ductal adenocarcinoma 3–5. With low
frequency and long latency, oncogenic KRAS-induced murine PanIN’s progress to invasive
cancer, a process that is markedly accelerated by either activation of Hedgehog signaling 6 or
inactivation of a variety of tumor suppressor genes, including Trp53, Ink4a/Arf, Tgfbr2 or
Smad4 4, 7–9. These studies have led to the view that oncogenic KRAS functions as a critical
initiator of pancreatic neoplasia, with additional genetic lesions required for tumor progression.
In spite of the known ability of oncogenic KRAS to initiate pancreatic neoplasia, the nature of
KRAS-induced initiating events remains unknown. To facilitate in vivo examination of
individual cells expressing oncogenic KRAS in the context of the exocrine pancreas, we have
developed technology for targeted transgene expression in developing zebrafish pancreas.
Utilizing this technology, we have generated a model of exocrine pancreatic cancer in
zebrafish, and have further identified a block in progenitor cell differentiation as one of the
earliest discernable effects of oncogenic KRAS expression in vertebrate exocrine pancreas.
Experimental Procedures
(See Supplemental Materials for detailed methods)
Generation of transgenic zebrafish
Using bacterial recombineering 10, we modified a genomic BAC (CH211-142H2) spanning
the zebrafish ptf1a locus to generate transgene constructs ptf1a:eGFP and ptf1a:eGFP-
KRASG12V. To enable real-time visualization of oncogenic KRAS expressing cells, the
KRASG12V transgene was expressed as eGFP fusion protein11. The purified ptf1a:eGFP and
ptf1a:eGFP-KRASG12V BAC transgenes were injected into single-cell stage wild-type AB
embryos, which were then raised to adulthood and outcrossed to generate F1 founders.
Analysis of Tumor Incidence in Adult Fish
To generate a population of fish in which to assess the time interval to visible tumor formation,
transgenic adult Tg(ptf1a:eGFP-KRASG12V) were outcrossed to wild-type fish and
approximately 200 heterozygous embryos expressing eGFP in the expected pattern were raised.
Transcutaneous eGFP expression was evaluated in a subset of the total number of fish at 1, 2,
3, 6 and 9 month time points. Fish with and without transcutaneous eGFP fluorescence were
sacrificed at interval time points for histologic evaluation.
Immunolabeling and In situ hybridization
Immunofluorescent and in situ hybridization analyses were performed either on whole embryos
or on 8µm cryosections as described previously 12. Primary antibodies used for
immunostaining, primers used to generate in situ probes, and methodology for multichannel
fluorescent intensity analysis are described in the Supplemental Material.
Quantitative RT-PCR
Real-time, quantitative RT-PCR was performed using an ABI Prism 7700 Sequence Detector
(Applied Biosystems), using the QuantiTect™ SYBR® Green PCR Kit (Qiagen). Primer
sequences are listed in the Supplemental Materials.
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Results
Generation of Tg(ptf1a:eGFP) and Tg(ptf1a:eGFP-KRASG12V) lines
In order to capture regulatory elements capable of targeting transgene expression to zebrafish
pancreatic progenitor cells, we engineered a large genomic BAC spanning the ptf1a locus, so
that ptf1a coding sequence was replaced with a cDNA encoding either eGFP alone or eGFP
fused to oncogenic human KRAS 4B (Figure 1A, Figure 2A; Supplemental Figure S1). Using
these BAC transgenes, seven independent Tg(ptf1a:eGFP) and six Tg(ptf1a:eGFP-
KRASG12V) lines were established. In the absence of significant variation between lines, a single
representative Tg(ptf1a:eGFP) line and a single representative Tg(ptf1a:eGFP-KRASG12V)
line were selected for further analysis.
The ptf1a:eGFP transgene recapitulates wild-type ptf1a expression
Examination of living ptf1a:eGFP embryos revealed expression in retinal amacrine cells,
hindbrain, spinal interneurons, and pancreas (Fig. 1, 2). This pattern faithfully recapitulated
the previously reported pattern of endogenous ptf1a expression 12–14. By crossing Tg
(ptf1a:eGFP) fish with fish expressing mCherry fluorescent protein under the regulation of
insulin promoter elements 15, we visualized the initial specification and migration of pancreatic
progenitor cells with respect to the already formed principle islet (Fig. 1). In addition to
expression in the early pancreatic progenitor pool, eGFP expression was subsequently observed
to persist in differentiated acinar cells throughout adult life (see Fig 3A and Fig 6A below).
Pancreatic expression of ptf1a:eGFP-KRASG12V becomes progressively restricted
We next compared patterns of eGFP fluorescence in Tg(ptf1a:eGFP) and Tg(ptf1a:eGFP-
KRASG12V) embryos. Expression of eGFP-KRASG12V in the retina, hindbrain and neural tube
was highly similar to the pattern seen in Tg(ptf1a:eGFP) embryos (Fig. 2F–K). However,
transgene expression in developing pancreas was much more heterogeneous among Tg
(ptf1a:eGFP-KRASG12V) embryos, with approximately 50% of transgenic embryos exhibiting
pancreatic expression levels which permitted serial imaging using a fluorescent
stereomicroscope. Pancreatic progenitor cells expressing eGFP-KRASG12V underwent initial
specification and migration in a manner identical to that observed in Tg(ptf1a:eGFP) embryos.
However, when individual embryos were serially imaged between 48 and 96 hours post
fertilization (hpf), we observed a noticeable decay in the intensity of eGFP-KRASG12V
expression (compare Fig. 2H,J with I,K). By 96 hpf, eGFP-KRASG12V expression was best
detected by confocal microscopy. Gradual loss of pancreatic eGFP fluorescence in the
ptf1a:eGFP-KRASG12V lines was also associated with loss of eGFP-KRASG12V transcripts as
assessed by whole mount in situ hybridization, even while transcripts for endogenous ptf1a
were found to persist (Supplemental Fig. S2 and data not shown).
Exocrine differentiation is blocked in pancreatic progenitor cells expressing eGFP-
KRASG12V
In order to assess the anatomic extent of pancreatic tissue in ptf1a:eGFP-KRASG12V
transgenics, and also to evaluate the ability of eGFP-KRASG12V-expressing pancreatic
progenitor cells to undergo normal exocrine differentiation, we performed immunofluorescent
labeling for the digestive enzyme carboxypeptidase A (CPA), a marker of exocrine
differentiation. When the dissected endodermal tissues of Tg(ptf1a:eGFP) larvae were
examined by confocal imaging at 96 hpf, eGFP-positive cells almost uniformly co-expressed
CPA in the apical cytoplasm, and showed well-developed apical secretory granules (Fig.
3A,C,E,G). In contrast to uniform expression of the ptf1a:eGFP transgene, pancreatic
expression of the eGFP-KRASG12V fusion protein demonstrated a mosaic pattern characterized
by the apparent random distribution of individual eGFP-positive cells and groups of cells (Fig.
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3B,D,F,H). Notably, progenitor cells maintaining expression of the fluorescent eGFP-
KRASG12V fusion protein showed negligible or extremely low levels of CPA expression, and
none developed CPA-positive, apical secretory granules (Fig 3, D,H). In the context of mosaic
expression of the eGFP-KRASG12V fusion protein, adjacent and surrounding cells of the
exocrine pancreas lacking detectable eGFP-KRASG12V expression showed high levels of CPA
in well-formed apical secretory granules. These data suggest that oncogenic KRAS cell
autonomously inhibits the differentiation of pancreatic progenitor cells.
In order to quantify the ability of oncogenic KRAS to block pancreatic progenitor cell
differentiation, we examined a series of optical sections of the pancreas from a total of 10
different embryos (n=4 for Tg(ptf1a:eGFP-KRASG12V) and n=6 for Tg(ptf1a:eGFP), and
compared the fraction of eGFP positive pixels which were also positive for Cy3 following
immunofluorescent staining for CPA. Similar to cell-by- cell FACS analysis, this pixel-by-
pixel analysis allowed us to determine the fraction of eGFP-positive area that is also positive
for CPA, providing a quantifiable estimate of exocrine differentiation among transgene-
expressing cells (Fig. 3I,J). In ptf1a:eGFP larvae at 96hpf, the fraction of eGFP-positive pixels
also positive for CPA was 16.0 ± 3.1% (mean ± SD), while the corresponding fraction in Tg
(ptf1a:eGFP-KRASG12V) larvae was 2.4 ± 1.4% (p<0.001, unpaired T-test). These observations
further support the conclusion that expression of oncogenic KRAS in exocrine pancreatic
progenitors prevents these cells from undergoing a normal pattern of exocrine differentiation,
resulting in the abnormal persistence of a ptf1a-positive, CPA-negative undifferentiated
progenitor pool.
Targeted expression of eGFP-KRASG12V results in eGFP-positive pancreatic tumors
Widespread eGFP expression was sustained in the pancreas of Tg(ptf1a:eGFP) fish during all
stages of development. This expression could be visualized transcutaneously in adult fish,
allowing the overall anatomic distribution of the exocrine pancreas to be visualized (Fig. 4A).
As previously reported 16, 17, adult zebrafish pancreas demonstrated a lobular configuration,
with pancreatic parenchyma interposed between loops of intestine and other viscera (Fig. 4B).
Over 200 Tg(ptf1a:eGFP-KRASG12V) fish were raised to adulthood. By the time these fish
reach the larval stage, transgene silencing has resulted in only small nests of eGFP-positive
cells that are detectable by confocal microscopy, but too small to be recognized by
transcutaneous fluorescence. However, as the fish aged, we observed the progressive onset of
transcutaneous fluorescence, suggesting expansion of eGFP-KRAS expressing cells. A random
subset of fish was periodically anesthetized and evaluated for abnormal patterns of
transcutaneous eGFP expression suggestive of tumor formation. In addition, a total of 32 adult
fish (18 with transcutaneous eGFP fluorescence patterns suggesting tumor formation and 14
fish without transcutaneous eGFP fluorescence) were sacrificed at different ages for detailed
histologic evaluation‥ At 1 month and 2 months of age, no transcutaneous fluorescence was
detected among 30 adult Tg(ptf1a:eGFP-KRASG12V) fish, consistent with widespread
transgene silencing observed in developing ptf1a:eGFP-KRASG12V embryos. Corresponding
to this absence of detectable fluorescence, 2 month old Tg(ptf1a:eGFP-KRASG12V) fish had
histologically normal pancreas and no evidence of tumor formation in any organ.
Transcutaneous abdominal eGFP fluorescence became detectable in a fraction of Tg
(ptf1a:eGFP-KRASG12V) fish at 3 months of age, at which time 20% of examined fish had
focal areas of abdominal eGFP expression (Fig. 4C,I). The proportion of fish with
transcutaneously-detectable eGFP-positive lesions increased with advancing age (Fig. 4I). At
6 months of age, 32% of fish had small (<8mm), focal eGFP-positive lesions, while 10%
showed larger (>8mm) or more diffuse/multifocal areas of eGFP fluorescence. By nine months
of age, two-thirds of examined fish had detectable tumor, and almost half had widespread
abdominal eGFP expression characterized by either multiple, discrete foci of eGFP expression
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or large masses encompassing a significant portion of the abdomen (Fig. 4D,F). Detailed
histologic examination of eighteen fish with either focal or diffuse abdominal eGFP expression
invariably revealed the presence of a pancreatic tumor (Fig 4G, H), and tumors associated with
widespread abdominal eGFP expression exhibited overt features of malignancy (discussed in
detail below). Among fourteen Tg(ptf1a:eGFP-KRASG12V) fish lacking transcutaneously
detectable eGFP fluorescence that were subjected to histologic analysis, one showed a small
tumor measuring less than 1mm in diameter, and one showed abnormal acinar cell hyperplasia
(Supplemental Table S1).
Phenotypic Characteristics of Pancreatic Tumors
Histologically normal exocrine pancreas from Tg(ptf1a:eGFP) fish is characterized by
delicately arborized clusters of pancreatic acini surrounded by adipose tissue, anatomically
insinuated among loops of bowel and surrounded by other visceral organs such as the liver,
spleen and gonads (Fig. 5A,B). Islet and ductal elements are also discernable (Fig. 5C).
Histologic examination of abdominal eGFP-positive lesions in Tg(ptf1a:eGFP-KRASG12V)
fish revealed tumor in each case (Table 1). Focal eGFP-positive lesions corresponded to small
pancreatic tumors comprised of disorganized proliferations of cells with recognizable acinar
morphology (Fig. 4G; Fig. 5E, 5F). Several fish with focal eGFP-positive tumors also showed
acinar cell “hyperplasia” characterized by well-organized, but abnormally abundant acinar
tissue (Fig. 5D). This feature was reminiscent of the enlarged but histologically normal
pancreas previously observed prior to pancreatic tumor formation in mice 3.
When examined histologically, all fish with large, widespread abdominal eGFP-positive
tumors showed defining features of malignancy: invasion of the pancreas and surrounding
organs and/or evidence of apparent metastasis (summarized in Table 1). These tumors
displayed considerable heterogeneity with respect to histologic patterns of differentiation, and
included acinar cell carcinoma, ductal adenocarcinoma, adenocarcinomas with mixed acinar
and ductal features, and mucinous (colloid) adenocarcinoma (FIG. 5E–L and Table 1). Among
nineteen tumors subjected to detailed histologic analysis, nine were classified as displaying
acinar or predominantly acinar differentiation (47%), five were classified as ductal or
predominantly ductal (26%), and five were classifed as mixed without acinar or ductal
predominance (26%). Tumors with predominantly ductal differentiation also displayed
dramatic stromal expansion, similar to that observed in human pancreatic cancer (Fig. 5G, Fig.
S3). Tumors were frequently observed to invade adjacent gut, liver and ovary, and were often
associated with considerable tissue destruction (Fig. 5M–P). Four examined fish had discrete
tumor nodules in the ovary and one fish was found to have tumor foci in a spinal vertebra and
adjacent spinal cord, suggesting possible hematogenous dissemination of tumor cells
(Supplemental Fig. S4). As in the case of primary tumors, metastatic lesions continued to
exhibit strong GFP fluorescence.
Morphologic assessment of tumor differentiation was confirmed by additional staining for
markers of acinar and ductal differentiation. In tumors with ductal features, invasive glandular
structures expressed cytokeratin 18 and contained intracytoplasmic mucin, as revealed by
immunofluorescent labeling and mucicarmine staining (Fig. 6A–D). To evaluate areas of
apparent acinar differentiation, additional immunohistochemistry was performed using the
acinar cell-specific markers, amylase and CPA (Fig. 6E–H). Acinar-like elements from eGFP-
KRASG12V-induced pancreatic tumors showed only low level or focal labeling, indicating a
significant degree of dedifferentiation. Histologic findings are summarized in Table 1.
In order to determine the status of downstream signaling pathways known to be activated by
oncogenic KRAS, we assessed levels of phospho-AKT and phospho-ERK using
immunohistochemistry (Fig. 7). In contrast to infrequent ERK and AKT phosphorylation in
normal zebrafish pancreas, eGFP-KRASG12V-induced pancreatic tumors exhibited widespread
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labeling for both phospho-ERK and phospho-AKT (Fig. 7A–D). Associated with activation
of these pathways, tumor cells expressing oncogenic KRAS fusion protein also demonstrated
an increased mitotic rate, as assessed by immunofluorescent staining for phospho-histone H3
(Fig. 7E–G).
Zebrafish Pancreatic Carcinomas Show Evidence of Active Hedgehog Signaling
Ligand-dependent activation of the hedgehog signaling pathway has been observed in invasive
human pancreatic cancer as well as in PanIN lesions, and forced hedgehog activation
accelerates progression of KRAS-induced tumors in mice 6, 21–23. We therefore evaluated
tumors for evidence of hedgehog pathway activation, using immunohistochemistry, in situ
hybridization and quantitative RT-PCR to assess expression of hedgehog pathway components
(Figure 8). These experiments revealed upregulated expression of shh, dhh, ihha, ihhb, ptc1,
gli1 and smo at the RNA level (Fig. 8G–K), and Ptc2 at the protein level (Fig. 8C and D), in
tumor epithelium compared to normal epithelium from ptf1a:eGFP transgenics. Among these
upregulated markers, ptc1 and gli1 represent known hedgehog target genes, thereby
representing surrogate markers of hedgehog pathway activation. These findings suggest that,
similar to the human disease, zebrafish pancreatic cancer is also characterized by activation of
hedgehog signaling.
Discussion
The successful modeling of human disease in experimental organisms often generates unique
insights with respect to initiating molecular and cellular events, and also provides a novel
platform for preclinical studies of early detection, chemoprevention and treatment. In the
current study, we have taken advantage of BAC recombineering technology to target
fluorescent transgene expression to ptf1a-expressing pancreatic progenitor cells, allowing us
to image the earliest events in zebrafish pancreas development, and to create a novel model of
zebrafish pancreatic cancer. In addition to providing new insights regarding the influence of
KRAS on the differentiation of pancreatic progenitor cells, these results also provide an
important proof-of-principle regarding the ability to generate pancreatic cancer in the zebrafish
species, and set the stage for future identification of genetic and small molecule modifiers of
pancreatic cancer initiation and progression.
As an example of the utility the zebrafish system, our studies have revealed a block in progenitor
differentiation and the attendant accumulation of undifferentiated progenitors as the earliest
discernable effects of oncogenic KRAS expression in vertebrate exocrine pancreas. While the
effects of oncogenic Ras proteins on cellular differentiation have frequently been examined in
the context of mammalian tissue culture 18, previous in vivo studies have typically been limited
by an inability to examine defined progenitor populations. However, a similar blockade in
progenitor cell differentiation has recently been reported following expression of oncogenic
KRAS in either hematopoietic or bronchoaveolar stem cells 19, 20. In both of these settings,
inhibition of differentiation was associated with expansion of an undifferentiated progenitor
pool, similar to the expansion of ptf1a-positive, CPA-negative cells observed in our Tg
(ptf1a:eGFP-KRASG12V) embryos.
EGFP-KRASG12V-induced zebrafish pancreatic cancers displayed specific similarities and
differences with respect to mouse and human pancreatic cancer. Similar to the aggressive
behavior of human pancreatic cancer, zebrafish pancreatic cancers were highly invasive, and
also demonstrated a propensity for apparent metastatic spread. Also similar to human
pancreatic cancer, many zebrafish tumors displayed areas of mucinous metaplasia and the
classical appearance of pancreatic ductal adenocarcinoma. In addition, the observed
upregulation of hedgehog pathway components suggests additional analogy between human,
mouse and zebrafish pancreatic cancer 3, 21–23. Unlike most human pancreatic cancer,
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however, we frequently observed features of non-ductal differentiation, especially in early
lesions. Further study will be required to determine what additional genetic and epigenetic
changes may occur in both ductal and non-ductal tumors, and to what degree these genetic
changes are required to support widespread expression of EGFP-KRASG12V.
The Tg(ptf1a:eGFP-KRASG12V) transgenic model of pancreatic cancer adds to a growing list
of zebrafish tumor models, including transgenic models of T- and B-cell leukemia 24–26,
pancreatic endocrine neoplasms 27, and melanoma 28. These zebrafish cancer models provide
a unique opportunity for studying interactions between known oncogenes and tumor suppressor
genes 28, or between genetic lesions and environmental carcinogens 29. In addition, these
models also provide novel platforms with which to conduct high throughput screens for both
genetic and small molecule modifiers of tumor progression 30. In addition to providing novel
insights regarding initiating events in pancreatic tumorigenesis, the current zebrafish model
will enable these approaches to be applied to the study of pancreatic cancer.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Visualization of pancreatic morphogenesis in living zebrafish embryos
A, Schematic depiction of utilized transgenes. B, Merged bright and dark field images of living
Tg(ptf1a:eGFP);(insulin:mCherry) double transgenic embryo at 34 hpf, demonstrating early
ptf1a-expressing pancreatic progenitor cells in left lateral endoderm (green arrow), and
principle islet located just to the right of the embryonic midline (red arrow). C, same embryo
at 40 hpf, demonstrating migration of ptf1a-expressing progenitor cells across the midline,
where they become affiliated with principle islet. D, time lapse imaging of pancreatic
progenitor migration.
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Fig. 2. Comparison of ptf1a:eGFP and ptf1a:GFP-KRASG12V transgene expression in living
zebrafish embryos
A, Schematic depiction of utilized transgenes, in which ptf1a coding sequence was replaced
with either eGFP or eGFP-KRASG12V coding sequence. B–E, Confocal images of retina (B
and C) and pancreas (D and E) at 48 hpf. Note nuclear and cytoplasmic localization of eGFP
in Tg(ptf1a:eGFP) embryos (B and D), compared to membrane localization of eGFP-
KRASG12V fusion protein (C and E), reflecting activity of KRAS C-terminal CAAX motif. F–
K, Whole mount dark field images of transgenic embryos, showing spatiotemporal expression
pattern of eGFP vs. eGFP-KRASG12V. F, H, and J. ptf1a:eGFP embryos. G, I, and K,
ptf1a:eGFP-KRASG12V embryos. eGFP-KRASG12V-expressing cells undergo normal
specification and initial migration, but eGFP-KRASG12V is subsequently downregulated
beginning at 48 hpf. White arrowheads indicate pancreatic domains of eGFP/ eGFP-
KRASG12V expression.
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Fig. 3. Pancreatic progenitor cells with persistent eGFP-KRASG12V expression fail to undergo
normal differentiation
A–H, Merged confocal images of microdissected pancreas from Tg(ptf1a:eGFP) and Tg
(ptf1a:eGFP-KRASG12V) larvae at 96 hpf. Green indicates eGFP or eGFP-KRASG12V
transgene expression, red Cy3 indicates immunofluorescent detection of carboxypeptidase A
(CPA), a marker of exocrine differentiation. Specimens in A–D were additionally labeled with
Hoechst dye. A and C, E and G represent low and high magnification images of Tg
(ptf1a:eGFP) pancreas. B and D, F and H represent low and high magnification images of Tg
(ptf1a:eGFP-KRASG12V) pancreas. In ptf1a:eGFP transgenic pancreas, virtually all eGFP-
expressing have undergone exocrine differentiation, indicated by accumulation of CPA protein
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in apical zymogen granules. In ptf1a:eGFP-KRASG12V- transgenic pancreas, the majority of
cells do not express the transgene, and are also positive for CPA, indicating normal
differentiation. In contrast, small clusters of cells with persistent eGFP-KRASG12V expression
are negative for CPA, indicating failure to undergo normal differentiation. Asterisks in A and
C indicate ptf1a:eGFP-negative principle islet. White arrowheads in A indicate eGFP-negative
pancreatic duct. For clarity, white dots outline individual cells in G, H. I and J, Pixel-by-pixel
determination of eGFP (y-axis) and CPA (x-axis) fluorescent intensity, allowing quantification
of eGFP/GFP-KRAS-G12V and CPA co-expression as a marker of exocrine differentiation
among transgene expressing cells. Area 2 comprises eGFP-positive pixels negative for CPA,
while area 3 comprises eGFP-positive pixels also positive for CPA. Area 1 comprises CPA-
positive pixels negative for GFP. The percentage of all eGFP-positive pixels labeling for CPA
in ptf1a:GFP transgenic pancreas (panel I; n=6) is 16.0 ± 3.1% (mean ± SD), compared to 2.4
± 1.4% in ptf1a:GFP-KRASG12V transgenics (panel J; n=4; p<0.001, unpaired T-test).
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Fig. 4. Pancreatic tumor formation in adult Tg(ptf1a:GFP-KRASG12V) fish visualized by
transcutaneous eGFP fluorescence
A, transcutaneous eGFP fluorescence in Tg(ptf1a:eGFP) fish, showing normal exocrine
pancreas. B, low and high power image of dissected abdominal viscera from Tg
(ptf1a:eGFP) fish, demonstrating multilobed pancreas interspersed between gut and other
visceral organs. C–F. Transcutaneous (C,D) and visceral (E,F) fluorescence in Tg(ptf1a:GFP-
KRASG12V) fish reveals eGFP-positive pancreatic tumors. Fish are designated as having either
focal (C,E) or diffuse (D,F) fluorescence depending on tumor volume. G and H, histologic
correlates of focal (G) and diffuse (H) transcutaneous eGFP fluorescence, confirming
pancreatic tumors (note change in scale between G and H). I, proportion of randomly sampled
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Tg(ptf1a:GFP-KRASG12V) fish with detectable fluorescent tumors, demonstrating age-
associated increase in tumor incidence and extent. Abbreviations: g, gut; t, tumor; li, liver.
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Fig. 5. Histological examination of normal adult zebrafish pancreas and eGFP-KRASG12V-induced
pancreatic tumors
A–C, Normal pancreas in ptf1a:eGFP transgenics Arrowhead in (A) indicates pancreatic
parenchyma surrounded by adipose tissue. D, increased size of exocrine pancreas (acinar
hyperplasia) in Tg(ptf1a:eGFP-KRASG12V) fish with separate pancreatic tumor. E and F,
Mixed adenocarcinoma with predominantly acinar cell differentiation and invasion of adjacent
gut. Black arrowheads in F indicate base of intestinal crypt. G and H, Invasive adenocarcinoma
with predominantly ductal differentiation and extensive desmoplastic reaction. Malignant
glands are shown invading adjacent gut in H. Black arrowheads in H indicate base of intestinal
crypt with adjacent goblet cells. I and J, adenocarcinoma with mixed acinar and glandular
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features. K and L, mucinous (colloid) adenocarcinoma. Note tumor cells floating in abundant
pools of extracellular mucin. M and N, immunohistochemical detection of eGFP-KRASG12V
expression in invasive adenocarcinoma invading adjacent gut. Image in (N) represents
magnified view of boxed area in (M). Black arrowheads in (M) indicate normal interface
between pancreas and intestine. Asterisk in (M) indicates ingested brine shrimp egg in the gut
lumen. O, invasion of adjacent liver by ductal adenocarcinoma. P, isolated tumor deposit
(asterisk) in ovary. Abbreviations: g, gut; p, pancreas; li, liver. Magnification: A, and M, 100x;
B, E, G, I, K, and P, 200x; C, D, F, H, J, L, N, and O, 400x.
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Fig. 6. Evaluation of differentiation and proliferation in normal adult zebrafish pancreas and
eGFP-KRASG12V-induced pancreatic tumors
A, mucicarmine stain highlighting intracytoplasmic mucin in intestinal goblet cells, but not in
adjacent normal pancreatic acinar cells (400x). B, Mucicarmine stain identifies
intracytoplasmic and intralumenal mucin in a eGFP-KRASG12V-induced pancreatic tumor with
ductal differentiation (400x). C and D (400x), immunofluorescent staining for Cytokeratin 18
reveals ductal elements in normal ptf1a:eGFP pancreas (C) and areas of ductal differentiation
in eGFP-KRASG12V-induced pancreatic tumor (D). E and F (400x), immunohistochemical
staining for amylase in normal pancreas (E) and eGFP-KRASG12V-induced pancreatic tumor
(F). Normal pancreas demonstrates strong expression of amylase in exocrine acinar cells, but
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not in endocrine islet (central area). Tumor in (F) shows acinar-like features, with some cells
staining positive for amylase. G and H (400x), immunohistochemical staining for
carboxypeptidase A (CPA) in normal pancreas (G) and eGFP-KRASG12V-induced pancreatic
tumor (F). Normal pancreas shows strong CPA expression in exocrine acinar cells. Tumor in
(H) shows acinar-like features, with some cells staining positive for CPA. I and J (400X),
immunofluorescent labeling for CPA in combination with eGFP fluorescence. G, normal
pancreas from Tg(ptf1a:eGFP) fish, showing widespread CPA expression in eGFP-positive
acinar cells. H, Pancreatic tumors from Tg(ptf1a:eGFP-KRASG12V) fish, demonstrating that
cells with high-level CPA expression are negative for the ptf1a:eGFP-KRASG12V transgene.
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Fig. 7. Assessment of ERK and AKT signaling in eGFP-KRASG12V-induced pancreatic tumors
A and B (200x), immunohistochemical detection of phosphorylated ERK in normal zebrafish
gut and pancreas (A), and in eGFP-KRASG12V-induced pancreatic tumor (B). C and D,
immunohistochemical detection of phosphorylated AKT in normal zebrafish gut and pancreas
(C), and in eGFP-KRASG12V-induced pancreatic tumor (D). Arrowheads in A–D indicate
labeling in intestinal crypts. E and F (400x), immunofluorescent labeling for phospho-histone
H3 (PHH3), a marker of proliferation, in normal pancreas from Tg(ptf1a:eGFP) fish (E), and
pancreatic tumor from Tg(ptf1a:eGFP-KRASG12V) fish (F). G, Phosphohistone H3-positive
cells per high power field (mean ± SEM).
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Fig. 8. Activation of hedgehog signaling pathway in eGFP-KRASG12V-induced pancreatic tumors
A and B, immunohistochemical stains for eGFP, showing transgene expression in exocrine
pancreas of adult Tg(ptf1a:eGFP) fish (A, 400X) and in tumor from Tg(ptf1a:eGFP-
KRASG12V) fish (B, 200X). C and D, immunohistochemical detection of Patched-2 in normal
pancreas (C, 400X) and in eGFP-KRASG12V-induced pancreatic tumor (D, 200X). Patched-2
is expressed in tumor epithelium, but is confined to stromal elements in normal pancreas. E
and F, in situ hybridization with eGFP probe detects eGFP expression in ptf1a:eGFP
transgenic pancreas (E, 200X) and eGFP-KRASG12V expression in ptf1a:eGFP-KRASG12V-
induced tumor (F, 200X). G and H, in situ hybridization for smoothened in normal pancreas
(G, 200X) and in eGFP-KRASG12V-induced pancreatic tumor (H, 200X). Smoothened
transcripts are detected in eGFP-KRASG12V-induced tumor, but not in normal pancreas. I and
J, in situ hybridization for gli1 in normal pancreas (I, 200X) and eGFP-KRASG12V-induced
pancreatic tumor (J, 200X). Transcripts for gli1 are detected in eGFP-KRASG12V-induced
tumor, but not in normal pancreas. K, quantitative RT-PCR confirms upregulated expression
of sonic hedgehog, desert hedgehog, indian hedgehog a, indian hedgehog b, patched-1,
smoothened and gli1, and downregulated expression of trypsin in eGFP-KRASG12V–induced
tumors relative to control pancreas. Values indicate mean ± SEM.
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Table 1
Histopathologic findings in selectively sacrificed Tg(ptf1a:GFP-KRASG12V) fish
Note that in the absence of defined routes for tumor dessemination in fish, interpretation of metastatic disease is viewed
as less than definitive.
Number Age at
sacrifice
(months)
Transcutaneous fluorescence Histology Invasion &
possible
metastasis
1 2 None No tumor
2 2 None No tumor
3 4 None No tumor
4 4 Focal Small tumor, acinar differentiation
5 6 None No tumor
6 6 None No tumor
7 6 None No tumor
8 6 None No tumor
9 6 None No tumor
10 6 Focal Small tumor, acinar differentiation
11 6 Focal Small tumor, acinar differentiation
12 6 Focal Small tumor, acinar differentiation,
acinar hyperplasia
13 6 Focal Small tumor, acinar differentiation,
acinar hyperplasia
14 6 Diffuse Large tumor, mixed acinar & ductal
differentiation
15 6 Diffuse Mixed acinar & ductal differentiation Liver & gut
invasion, ovarian
metastasis
16 6 Diffuse Predominantly ductal differentiation Gut invasion
17 8 None No tumor
18 8 None No tumor
19 8 None No tumor
20 8 None No tumor
21 8 None No tumor, acinar hyperplasia
22 8 None Small tumor, acinar differentiation,
acinar hyperplasia
23 8 Focal Small tumor, acinar differentiation,
acinar hyperplasia
24 8 Focal Small tumor, ductal differentiation
25 8 Focal Small tumor, mixed acinar & ductal
differentiation
26 8 Diffuse Mixed predominantly acinar
differentiation
Invasion of muscle
and ovary, spinal
metastasis
27 8 Diffuse Mixed acinar & ductal differentiation Ovarian metastasis
28 8 Diffuse Mixed acinar & ductal differentiation Liver & gut
invasion, ovarian
metastasis
29 8 Diffuse Mixed predominantly ductal
differentiation
Liver & gut
invasion
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Number Age at
sacrifice
(months)
Transcutaneous fluorescence Histology Invasion &
possible
metastasis
30 11 Diffuse Ductal/mucinous differentiation Liver and ovary
invasion
31 11 Diffuse Mixed predominantly ductal
differentiation
Ovary invasion
32 11 Diffuse Mixed predominantly acinar
differentiation
Gut and liver
invasion
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